scholarly article | Q13442814 |
P356 | DOI | 10.1089/GTE.1999.3.237 |
P698 | PubMed publication ID | 10464675 |
P2093 | author name string | Das S | |
Feldman D | |||
Mark HF | |||
Samy M | |||
Sun CL | |||
Lathrop J | |||
P2860 | cites work | Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization | Q29616823 |
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen | Q52827123 | ||
P433 | issue | 2 | |
P304 | page(s) | 237-242 | |
P577 | publication date | 1999-01-01 | |
P1433 | published in | Genetic Testing and Molecular Biomarkers | Q15753742 |
P1476 | title | HER-2/neu oncogene amplification in cervical cancer studied by fluorescent in situ hybridization | |
P478 | volume | 3 |
Q42285872 | Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence |
Q24792559 | HER2 expression in cervical cancer as a potential therapeutic target |
Q33918707 | Loss of sequences on the short arm of chromosome 17 is a late event in squamous carcinoma of the cervix. |
Q57218329 | Selection of HER-2/neu-positive tumor cells in early stage cervical cancer: implications for Herceptin-mediated therapy |
Q53890793 | The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial. |
Search more.